Acute inhibition of Drp1-mediated mitochondrial fission using DRPi27, delivered in a novel cardiac-targeted PLGA nanoparticle formulation (“Nano-DRPi27”), for cardioprotection in the setting of ischaemia-reperfusion injury.

  • Lim, Shiang Yong (Primary Chief Investigator (PCI))
  • McCarthy, Davis (Chief Investigator (CI))
  • Hausenloy, Derek (Chief Investigator (CI))
  • Shen, Hsin-Hui (Chief Investigator (CI))

Project: Research

Project Details

Short titleA new nanodrug to protect the heart from damage after heart attack
StatusFinished
Effective start/end date1/01/21 → 30/12/22

Keywords

  • nanoparticles
  • cardioprotection